NASDAQ · MPLT
MapLight Therapeutics, Inc.
$7.72-$0.26 (-3.26%)
MapLight Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.91% below the high.
Loading market information…
AMEX · AMS · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
American Shared Hospital Services’s quoted price sits in the lower half of its reported 52-week range, 47.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
American Shared Hospital Services’s forward annual dividend is $0.19 per share, paid quarterly. The forward yield is 15.08% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
American Shared Hospital Services’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of $0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow American Shared Hospital Services’s reporting calendar.
THE COMPANY BEHIND THE TICKER
American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditions such as malignant and benign brain tumors, arteriovenous malformations, and trigeminal neuralgia. They also facilitate financing for Leksell Gamma Knife units. Additionally, the firm operates proton beam radiation therapy centers in Orlando, Florida, and Long Beach, California. Customers further benefit from comprehensive support encompassing planning, installation, reimbursement guidance, and marketing strategies. As of December 31, 2021, their portfolio included 115 active Gamma Knife units across the United States, complemented by two units in South America (Lima, Peru, and Guayaquil, Ecuador), and one proton beam radiation therapy system. Established in 1980, American Shared Hospital Services maintains its headquarters in San Francisco, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:42 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 15, 2025 | -$0.10-350.0% vs estimate | $6.11M-29.18% vs estimate |
|---|
| Q1 2025 | Apr 4, 2025 | -$0.20-2,100.0% vs estimate | $9.07M+17.78% vs estimate |
|---|
| Q3 2024 | Nov 13, 2024 | -$0.03-137.5% vs estimate | $7.00M-9.1% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$7.72-$0.26 (-3.26%)
MapLight Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.91% below the high.
$11.08+$0.01 (+0.09%)
ProMIS Neurosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.56% below the high.
$15.90-$1.74 (-9.86%)
Ekso Bionics Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 40.14% below the high.
$11.05-$1.21 (-9.87%)
Burning Rock Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 73.51% below the high.
$7.02+$0.28 (+4.08%)
enVVeno Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.37% below the high.
$2.11+$0.13 (+6.57%)
Ernexa Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.6% below the high.
$0.40-$0.05 (-10.49%)
Co-Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.41% below the high.
$5.52-$0.03 (-0.54%)
Aethlon Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.6% below the high.
